Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's

被引:17
|
作者
Borbon, Ivan A. [1 ]
Erickson, Robert P. [1 ,2 ]
机构
[1] Univ Arizona, Hlth Sci Ctr, Dept Pediat, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA
关键词
A beta 42; Alzheimer's; Niemann-Pick C; Npc1; NIEMANN-PICK C1; PRECURSOR-PROTEIN; CHOLESTEROL TRANSPORT; BETA DEPOSITION; DISEASE; GENE; PATHOLOGY; MICE; MUTANT; APP;
D O I
10.1007/s13353-010-0021-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Although Niemann-Pick C1 disease has frequently been called "juvenile Alzheimer's", the effects of introducing Npc1 mutations into a mouse model of Alzheimer's have not previously been performed. We have crossed Npc1 (+/-) mice with APP/PS1 "Alzheimer's" mice and studied A beta 42 accumulation and amyloid plaque formation. Mice heterozygous for Npc1 and positive for the APP and PS1 transgenes accumulated A beta 42 more rapidly than the APP/PS1 controls and this correlated, as expected, with the area of amyloid plaques. We conclude that the alterations of intracellular cholesterol present in Npc1 (+/-) mice can influence the progress of Alzheimer's disease in the APP/PS1 mouse model.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 50 条
  • [1] Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer’s
    Ivan A. Borbon
    Robert P. Erickson
    Journal of Applied Genetics, 2011, 52 : 213 - 218
  • [2] Seizure susceptibility in the APP/PS1 mouse' model of Alzheimer's disease and relationship with amyloid β plaques
    Reyes-Marin, Karen E.
    Nunez, Angel
    BRAIN RESEARCH, 2017, 1677 : 93 - 100
  • [3] Aβ deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease
    Howlett, D. R.
    Bowler, K.
    Soden, P. E.
    Riddell, D.
    Davis, J. B.
    Richardson, J. C.
    HISTOLOGY AND HISTOPATHOLOGY, 2008, 23 (01) : 67 - 76
  • [4] Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease
    Oliver Wirths
    Joachim Weis
    Jacek Szczygielski
    Gerd Multhaup
    Thomas A. Bayer
    Acta Neuropathologica, 2006, 111 : 312 - 319
  • [5] Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease
    Wirths, O
    Weis, J
    Szczygielski, J
    Multhaup, G
    Bayer, TA
    ACTA NEUROPATHOLOGICA, 2006, 111 (04) : 312 - 319
  • [6] The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease
    Zhu, Shenghua
    Wang, Junhui
    Zhang, Yanbo
    He, Jue
    Kong, Jiming
    Wang, Jun-Feng
    Li, Xin-Min
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (04) : 310 - 320
  • [7] Influence of β-Amyloid Plaques on the Local Network Activity in the APP/PS1 Mouse Model of Alzheimer's Disease
    Castano-Prat, Patricia
    Aparicio-Torres, Guillermo
    Munoz, Alberto
    Sanchez-Vives, Maria V.
    ADVANCES IN COGNITIVE NEURODYNAMICS (VI), 2018, : 245 - 253
  • [8] Dysregulation of Histone Acetylation in the APP/PS1 Mouse Model of Alzheimer's Disease
    Francis, Yitshak I.
    Fa, Mauro
    Ashraf, Haider
    Zhang, Hong
    Staniszewski, Agnieszka
    Latchman, David S.
    Arancio, Ottavio
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (01) : 131 - 139
  • [9] Vascular and metabolic dysfunctions in APP/PS1 mouse model of Alzheimer's disease
    Iordanova, B.
    Fukuda, M.
    Klunk, W.
    Vazquez, A. L.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 44 - 45
  • [10] Mechanical alterations of the hippocampus in the APP/PS1 Alzheimer's disease mouse model
    Antonovaite, Nelda
    Hulshof, Lianne A.
    Huffels, Christiaan F. M.
    Hol, Elly M.
    Wadman, Wytse J.
    Iannuzzi, Davide
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2021, 122